Telomir Pharmaceuticals Inc
TELO
$5.97
Closing
▼-0.50%
1D
YTD
TELO
BBG01K4SG4R3
Market cap
$176.77M
52 week high
$20.71
52 week low
$3.19
Volume
17,227
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$176.77M
Analysts' Rating
-
Price Target (Mean)
0.00
Total Analysts
0
P/E
Operating Margin
0.00%
Beta
Revenue Growth
0.00%
52 week high
$20.71
52 week low
$3.19
Div. Yield
%
EPS Growth
0.00
Company Profile
Telomir Pharmaceuticals, Inc. is a United States-based company. The Company operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acid’s (DNA) protective telomere caps to affect age reversal. It selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.
